Monkeypox declared global health emergency
July 25, 2022Sales and Marketing
For the second time in two years, WHO declared a global health emergency, this time for monkeypox. The declaration is …
MPs warn NHS in England facing worst staffing crisis in history
July 25, 2022Sales and Marketing
A recent report by MPs say that the large number of unfilled NHS job vacancies is posing a serious risk …
NICE recommend new early targeted treatment for breast cancer
July 22, 2022Medical Communications
Abemaciclib (Verzenios) has been approved by the NICE to treat some people with breast cancer that has a high-risk of …
£70 million in fines for pharma firms that overcharged NHS
July 22, 2022Medical Communications
The CMA has found that Pfizer and Flynn charged unfairly high prices for phenytoin sodium capsules for over four years, …
Otsuka receives positive CHMP opinion for lupus nephritis treatment
July 22, 2022Medical Communications
The CHMP has adopted a positive opinion relating to the use of Lupkynis (voclosporin) in combination with mycophenolate mofetil for …
Cancer Research UK agreement to advance cancer immunotherapy candidate
July 22, 2022Medical Communications
Cancer Research UK and Sosei Heptares have announced the signing of an agreement to bring Sosei Heptares’ cancer immunotherapy drug …
UK scientists say they have found cancer driver in junk DNA
July 21, 2022Business Services
Scientists in the UK think they have understood the mechanism behind junk DNA, which is implicated in cancer. Junk DNA …
Strategic alliance for treatment of glaucoma
July 21, 2022Business Services
AbbVie and iSTAR Medical SA have announced a strategic transaction to further develop and commercialise iSTAR Medical’s MINIject® device. The …
First disease-modifying treatment for AADC deficiency
July 21, 2022Business Services
The European Commission (EC) has granted a marketing authorisation for Upstaza™ (eladocagene exuparvovec), the world’s first disease-modifying treatment for aromatic …
Transformational therapy cures bleeding disorder haemophilia B
July 21, 2022Business Services
Researchers have found that a single injection of a new gene therapy, called FLT180a, removed the need for people to …
Depression may not be caused by chemical imbalance
July 20, 2022Research and Development
A major review has found “no clear evidence” that low serotonin levels are responsible for depression. Reviewing existing studies, researchers …
COVID-19 boosters to be offered to all over 50s this autumn
July 20, 2022Research and Development
All those aged 50 and over will be offered a COVID-19 booster vaccine this autumn, to top up their immunity …
Potential shortage of 140,000 nurses in NHS England by 2030
July 20, 2022Research and Development
According to new analysis, the NHS in England could face a shortfall of almost 40,000 nurses by 2024, and under …
TSB and CR Pharma partner for COVID-19 antibody therapy in China
July 20, 2022Research and Development
TSB Therapeutics has entered a collaboration with China Resources Pharmaceutical Commercial Group (CR Pharma) for the commercialisation of an antibody …
Brain cancer treatment receives Orphan Drug Designation
July 19, 2022Manufacturing and Production
The FDA has granted an Orphan Drug Designation for DSP-0390, an investigational emopamil-binding protein (EBP) inhibitor for the treatment of …
MIT research demonstrates potential of self-boosting vaccines
July 19, 2022Manufacturing and Production
In a new study, MIT researchers describe the analysis of a release mechanism from biodegradable core-shell microparticles.Through understanding how and …
New reforms aim for better NHS dental service access
July 19, 2022Manufacturing and Production
Patients across the country will benefit from improved access to dental care under changes announced by NHS England, the organisation …
WHO to assist Ghana following confirmed Marburg cases
July 19, 2022Manufacturing and Production
WHO has announced that in the coming days it will deploy a team of experts to assist Ghana in tackling …
FDA approval for neurostimulation device to treat diabetic neuropathic pain
July 15, 2022Medical Communications
DyAnsys has received FDA approval for its First Relief device, a wearable device monitoring pulses of a low-level electrical current …
Step strategy effective in treating diabetic eye disease
July 15, 2022Medical Communications
An NIH-funded clinical from the DRCR Retina Network suggests that a specific step strategy for patients with diabetic macular edema …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
